<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34711146</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2209-6051</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><PubDate><Year>2021</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Communicable diseases intelligence (2018)</Title><ISOAbbreviation>Commun Dis Intell (2018)</ISOAbbreviation></Journal><ArticleTitle>Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2020.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.33321/cdi.2021.45.59</ELocationID><Abstract><AbstractText>For 27 years, national prospective data on selected rare childhood diseases have been collected monthly by the Australian Paediatric Surveillance Unit (APSU) from paediatricians and other clinical specialists who report cases in children aged up to 16 years. We report here the annual results of APSU surveillance in 2020 for ten rare communicable diseases and complications of communicable diseases, namely: acute flaccid paralysis (AFP); congenital cytomegalovirus (CMV) infection; neonatal herpes simplex virus (HSV) infection; perinatal exposure to human immunodeficiency virus (HIV); paediatric HIV infection; severe complications of seasonal influenza; juvenile onset recurrent respiratory papillomatosis (JoRRP); congenital rubella syndrome; congenital varicella syndrome; and neonatal varicella infection. We describe the results for each disease in the context of the total period of study, including demographics, clinical characteristics, treatment and short-term outcomes. Despite challenges presented by the coronavirus disease 2019 (COVID-19) pandemic in 2020, more than 1,400 paediatricians reported regularly to the APSU and an overall monthly reporting rate of &gt; 90% was achieved. The minimum AFP target of 1 case per 100,000 children aged less than 15 years was achieved and there were few cases of vaccine-preventable diseases (JoRRP, rubella, varicella). However, high cases of congenital CMV, neonatal HSV and perinatal exposure to HIV persist. There were no severe complications of seasonal influenza reported for the first time in 13 years. This is consistent with other surveillance data reporting a decline of influenza and other communicable diseases in 2020, and likely reflects the wider effects of public health measures to reduce transmission of SARS-CoV-2 in the Australian community.</AbstractText><CopyrightInformation>Â© Commonwealth of Australia CC BY-NC-ND.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Teutsch</LastName><ForeName>Suzy M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>The Australian Paediatric Surveillance Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Sydney, Faculty of Medicine and Health, Discipline of Child and Adolescent Health, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sydney Children's Hospitals Network, Westmead, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nunez</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>The Australian Paediatric Surveillance Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Sydney, Faculty of Medicine and Health, Discipline of Child and Adolescent Health, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sydney Children's Hospitals Network, Westmead, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Australian Paediatric Surveillance Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Sydney, Faculty of Medicine and Health, Discipline of Child and Adolescent Health, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sydney Children's Hospitals Network, Westmead, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eslick</LastName><ForeName>Guy D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>The Australian Paediatric Surveillance Unit.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Sydney, Faculty of Medicine and Health, Discipline of Child and Adolescent Health, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sydney Children's Hospitals Network, Westmead, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khandaker</LastName><ForeName>Gulam</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Director of Public Health/Public Health Physician and Director of Medical Research, Central Queensland Hospital and Health Service, Rockhampton, Queensland, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berkhout</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Microbiology Registrar, Microbiology and laboratory services, The Royal Children's Hospital, Melbourne, Victoria, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novakovic</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>ENT, Head and Neck Surgeon, Laryngologist, and Director, Dr Liang Voice Program, The University of Sydney, Faculty of Medicine and Health, Central Clinical School, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brotherton</LastName><ForeName>Julia M L</ForeName><Initials>JML</Initials><AffiliationInfo><Affiliation>Medical Director, VCS Population Health, VCS Foundation, Melbourne, Victoria, AUSTRALIA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Honorary Principal Fellow, Melbourne School of Population and Global Health, University of Melbourne, Victoria, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGregor</LastName><ForeName>Skye</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epidemiologist, The Kirby Institute, UNSW Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Epidemiologist, The Kirby Institute, UNSW Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egilmezer</LastName><ForeName>Ece</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Virology Research Laboratory, Prince of Wales Hospital, Randwick, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UNSW Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Booy</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Senior Professorial Fellow, National Centre for Immunisation Research and Surveillance, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Cheryl A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Dean and Head of Sydney Medical School, The University of Sydney, Faculty of Medicine and Health, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawlinson</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Senior Medical Virologist, Director of Serology, Virology and OTDS Laboratories, NSW Health Pathology Randwick, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UNSW Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorley</LastName><ForeName>Bruce R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Head, National Enterovirus Reference Laboratory and WHO Polio Regional Reference Laboratory, Victorian Infectious Disease Reference Laboratory, Melbourne, Victoria, AUSTRALIA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, AUSTRALIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elliott</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>The University of Sydney, Faculty of Medicine and Health, Discipline of Child and Adolescent Health, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Sydney Children's Hospitals Network, Westmead, Sydney, New South Wales, AUSTRALIA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Commun Dis Intell (2018)</MedlineTA><NlmUniqueID>101735394</NlmUniqueID><ISSNLinking>2209-6051</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Australia</Keyword><Keyword MajorTopicYN="N">child</Keyword><Keyword MajorTopicYN="N">communicable disease</Keyword><Keyword MajorTopicYN="N">public health surveillance</Keyword><Keyword MajorTopicYN="N">rare disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34711146</ArticleId><ArticleId IdType="doi">10.33321/cdi.2021.45.59</ArticleId></ArticleIdList></PubmedData></PubmedArticle>